GET THE APP

Medication-induced osteoporosis: What’s the challenge in the field of dermatology?
Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+1-504-608-2390

Medication-induced osteoporosis: What’s the challenge in the field of dermatology?


5th International Conference on Clinical & Experimental Dermatology

July 13-15, 2015 New Orleans, USA

Farrokh Khosravi and Reza F Ghohestani

ScientificTracks Abstracts-Workshop: J Clin Exp Dermatol Res

Abstract :

Drug induced osteoporosis (DIO) represents about 20% of all cases affected by Osteoporosis. DIO is one of the most challenging health issues in the elderly patients affected by various skin diseases. Any attempt to prevent or treat DIO will significantly decrease patients morbidity and mortality. Novel drugs have been recently developed for prevention and/or treatment of DIO. New methods of detection, prevention and treatment of DIO will be discussed.

Biography :

Farrokh Khosravi, M.D., has completed his fellowship of Rheumatology at the age of 38 years from Shiraz University. He is a part time Assistant Professor of Medicine. His field of interest is autoimmune skin disease and has published several papers in peer reviewed journals and served as a reviewer for Various Medical Journals.

Top